vTv Therapeutics (VTVT) 10-Q2018 Q1 Quarterly report

Filed: 15 May 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absence, accomplish, adjunct, adjusted, alternative, Altstiel, amendment, announced, announcement, attract, Australia, automatically, back, bankruptcy, baseline, bid, biotechnology, Black, blood, Bulletin, calendar, cancellation, capable, care, China, closure, cognitive, commonly, component, comprised, concentration, confirmed, consecutive, contrast, costly, country, covered, covering, cumulative, de, decline, deduction, delist, delisted, delisting, delta, Dementia, departure, diagnostic, discernable, discontinuation, discontinued, discontinuing, distinct, dose, efficacy, eligible, employment, enacted, enactment, endpoint, entrance, entry, exemption, experienced, expertise, extend, extended, face, fully, gain, group, guarantee, Hangzhou, harm, harmed, hoc, holder, Huadong, identical, iii, immaterial, impair, impairment, impede, impossible, improve, improved, improvement, incentive, incomplete, incremental, indirectly, influence, intense, interpretation, iv, January, JDC, joint, key, knowledge, Korea, label, Larry, leave, legislation, letter, level, margin, measure, measured, measurement, mild, minimum, mix, motivate, MRCT, NASDAQ, notice, notification, observable, observed, open, opening, order, orderly, organization, oversee, Pacific, pattern, peak, peroxisome, placebo, plasma, point, pool, population, post, PPAR, President, prespecified, proliferation, prophylactic, proportional, provisional, purpose, randomized, ranging, reached, readily, reduction, refine, reform, regain, regained, regulation, remaining, remeasured, Reneo, Replacing, response, responsible, retain, Rim, SAB, safety, sample, SAP, scale, Section, send, shortly, showed, smaller, South, sponsor, sponsoring, standalone, Statistical, statistically, subgroup, subpopulation, subscale, substance, sum, supply, TCJA, terminate, termination, Territory, therapeutic, thirty, topline, train, unadjusted, unobservable, unsuccessful, vest, Vice, wind, withdrawal, worse, worth, Zhongmei

Removed: accept, acquisition, advanced, agent, alliance, allocate, antagonist, assured, borrow, borrowing, Calithera, Cambrex, clarify, collaborative, collection, compliant, core, curve, deliverable, delivered, depict, determining, division, enable, establish, established, evaluate, fixed, forfeited, formula, forward, fulfill, function, glycation, granting, hexokinase, identifying, implementation, increasing, interaction, lack, lead, led, muscle, operate, outsourcing, owe, persuasive, PharmaCore, pipeline, planned, principle, projected, promised, prospective, qualitative, quantitative, RAGE, reimbursable, Reorganization, separation, substantive, Subtopic, targeting, Treasury, usage

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

VTVT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of vTv Therapeutics Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen L. Holcombe, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of the Company that, to my knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 15, 2018

By:		/s/ Stephen L. Holcombe
		Stephen L. Holcombe
		President and Chief Executive Officer